Previous close | 1.5950 |
Open | 1.5900 |
Bid | 1.5400 x 100 |
Ask | 1.6200 x 100 |
Day's range | 1.5700 - 1.6100 |
52-week range | 1.0800 - 2.7000 |
Volume | |
Avg. volume | 559,864 |
Market cap | 106.667M |
Beta (5Y monthly) | 1.23 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.9400 |
Earnings date | 07 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 22.60 |
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in two upcoming investor conferences scheduled to take place in April 2024. Details of the conferences appear below: Conference: Evercore ISI Diamonds in the Rough Webinar DayDate: Thursday, April 4, 2024 Time: 10:3
aTyr Pharma ( NASDAQ:LIFE ) Full Year 2023 Results Key Financial Results Net loss: US$50.4m (loss widened by 11% from...